Lung and COVID-19
Lung complications from COVID-19 can range from mild inflammation to severe respiratory distress, as the virus primarily affects the lungs, causing damage and impairing oxygen exchange. Severe cases may lead to acute respiratory distress syndrome (ARDS) and require intensive care, including mechanical ventilation. Ongoing research aims to understand long-term lung effects and improve treatment strategies for COVID-19-related lung damage.
Related Conference of Lung and COVID-19
October 24-25, 2024
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Paris, France
November 28-29, 2024
16th International Conference on Chronic Obstructive Pulmonary Disease
Paris, France
Lung and COVID-19 Conference Speakers
Recommended Sessions
- Asthma Management
- Asthma-COPD Overlap
- Chronic Obstructive Pulmonary Disease
- Clinical Immunology & Genetics
- Clinical Trials
- COPD Pathogenesis
- COPD Preventative Measures
- Depression and Anxiety in COPD
- Diagnosis and Treatment of COPD
- Drug Discovery of COPD
- Effect of COVID-19 on Lungs
- Epidemiology
- Experimental Models
- Lung and COVID-19
- Lung Transplantation
- Pathophysiology & Pharmacology
- Pharmacological and Non-Pharmacological Treatments
- Pulmonary Rehabilitation
- Respiratory Failure
- Self-Management and Prevention of COPD
- Spirometry
Related Journals
Are you interested in
- Asthma - Tuberculosis-2024 (France)
- Asthma - Pulmonary Meet 2024 (France)
- Asthma and Allergy - COPD CONGRESS 2024 (UK)
- Asthma and COPD - COPD_2024 (France)
- Asthma Management - COPD SUMMIT 2025 (Italy)
- Asthma-COPD Overlap - COPD SUMMIT 2025 (Italy)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - COPD CONGRESS 2024 (UK)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic bronchitis - COPD CONGRESS 2024 (UK)
- Chronic Bronchitis - Pulmonary Meet 2024 (France)
- Chronic Obstructive Pulmonary Disease - COPD_2024 (France)
- Chronic Obstructive Pulmonary Disease - COPD SUMMIT 2025 (Italy)
- Chronic obstructive pulmonary disease - COPD CONGRESS 2024 (UK)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- Clinical Immunology & Genetics - COPD SUMMIT 2025 (Italy)
- Clinical Trials - COPD SUMMIT 2025 (Italy)
- Co-Morbidities of COPD - COPD_2024 (France)
- COPD - Pulmonary Meet 2024 (France)
- COPD and Air Pollution - COPD CONGRESS 2024 (UK)
- COPD and Cardiovascular Diseases - COPD_2024 (France)
- COPD Complications - COPD_2024 (France)
- COPD Exacerbations - COPD_2024 (France)
- COPD Pathogenesis - COPD CONGRESS 2024 (UK)
- COPD Pathogenesis - COPD_2024 (France)
- COPD Pathogenesis - COPD SUMMIT 2025 (Italy)
- COPD Preventative Measures - COPD SUMMIT 2025 (Italy)
- COPD Therapeutics - COPD_2024 (France)
- COPD-Chronic obstructive pulmonary disease - COPD CONGRESS 2024 (UK)
- COPD: Sign and Symptoms - COPD_2024 (France)
- Cystic Fibrosis - Pulmonary Meet 2024 (France)
- Depression and Anxiety in COPD - COPD CONGRESS 2024 (UK)
- Depression and anxiety in COPD - COPD_2024 (France)
- Depression and Anxiety in COPD - COPD SUMMIT 2025 (Italy)
- Diagnosis and Treatment of COPD - COPD CONGRESS 2024 (UK)
- Diagnosis and Treatment of COPD - COPD SUMMIT 2025 (Italy)
- Drug Discovery of COPD - COPD CONGRESS 2024 (UK)
- Drug Discovery of COPD - COPD_2024 (France)
- Drug Discovery of COPD - COPD SUMMIT 2025 (Italy)
- Effect of COVID-19 on Lungs - COPD CONGRESS 2024 (UK)
- Effect of COVID-19 on Lungs - COPD SUMMIT 2025 (Italy)
- Emphysema - COPD CONGRESS 2024 (UK)
- Emphysema - Pulmonary Meet 2024 (France)
- Epidemiology - COPD SUMMIT 2025 (Italy)
- Epidemiology of COPD - COPD_2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Experimental Models - COPD SUMMIT 2025 (Italy)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Genetic risk factor of COPD - COPD_2024 (France)
- Infectious Respiratory Diseases - Pulmonary Meet 2024 (France)
- Interstitial lung disease - Pulmonary Meet 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung and COVID-19 - COPD SUMMIT 2025 (Italy)
- Lung cancer - COPD CONGRESS 2024 (UK)
- Lung cancer - COPD_2024 (France)
- Lung Cancer - Pulmonary Meet 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - COPD CONGRESS 2024 (UK)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung problems - Pulmonary Meet 2024 (France)
- Lung Transplantation - COPD CONGRESS 2024 (UK)
- Lung transplantation - Pulmonary Meet 2024 (France)
- Lung Transplantation - COPD SUMMIT 2025 (Italy)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pathophysiology & Pharmacology - COPD SUMMIT 2025 (Italy)
- Pathophysiology of COPD - COPD_2024 (France)
- Pediatric Neonatal Care in COPD - COPD CONGRESS 2024 (UK)
- Pediatric Pulmonary, Critical care and Sleep - COPD_2024 (France)
- Pediatric Pulmonology & Critical care - COPD CONGRESS 2024 (UK)
- Pharmacological and Non-Pharmacological Treatments - COPD SUMMIT 2025 (Italy)
- Pleural Diseases - Pulmonary Meet 2024 (France)
- Prevention and Control of Respiratory disease - Pulmonary Meet 2024 (France)
- Prevention of COPD - COPD CONGRESS 2024 (UK)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary diseases - COPD CONGRESS 2024 (UK)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases-treatment and therapies - COPD_2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - COPD_2024 (France)
- Pulmonary Hypertension - Pulmonary Meet 2024 (France)
- Pulmonary Rehabilitation - COPD CONGRESS 2024 (UK)
- Pulmonary Rehabilitation - Pulmonary Meet 2024 (France)
- Pulmonary Rehabilitation - COPD SUMMIT 2025 (Italy)
- Pulmonary vascular disease - Pulmonary Meet 2024 (France)
- Pulmonology - Pulmonary Meet 2024 (France)
- Respiratory and sleep Medicine - COPD CONGRESS 2024 (UK)
- Respiratory Disorders - Pulmonary Meet 2024 (France)
- Respiratory Failure - COPD SUMMIT 2025 (Italy)
- Respiratory Failure and COPD Complications: - COPD CONGRESS 2024 (UK)
- Respiratory Tract Infections - COPD CONGRESS 2024 (UK)
- Respiratory Tract Infections - Pulmonary Meet 2024 (France)
- Self-Management and Prevention of COPD - COPD CONGRESS 2024 (UK)
- Self-Management and Prevention of COPD - COPD_2024 (France)
- Self-Management and Prevention of COPD - COPD SUMMIT 2025 (Italy)
- Sleep-Related Respiratory Disorders - Pulmonary Meet 2024 (France)
- Spirometry - COPD CONGRESS 2024 (UK)
- Spirometry - COPD SUMMIT 2025 (Italy)
- Stages & Severity on Lung Diseases - COPD CONGRESS 2024 (UK)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tobacco control - COPD CONGRESS 2024 (UK)
- Tuberculosis - Pulmonary Meet 2024 (France)
- Types of COPD - COPD CONGRESS 2024 (UK)
- Types of COPD - COPD_2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)